IHS Chemical Week

People & Business :: People/Executives

Merck KGaA appoints Simon Sturge as new head of biosimilars unit

3:27 AM MST | February 20, 2014 | Deepti Ramesh

Merck KGaA says that Simon Sturge will join the company from Boehringer Ingelheim (Ingelheim, Germany) effective 1 March 2014, to head the biosimilars unit. The Simon Sturge. biosimilars unit is part of Merck’s pharmaceutical businesses alongside with Merck Serono (Darmstadt, Germany), the consumer health division and the Allergopharma unit. Sturge, in his new role, will report to Stefan Oschmann, member of Merck’s executive board and responsible for the company’s pharmaceutical businesses. Sturge succeeds Thierry Hulot, who created the...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa